Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6924-6930

  Basilio De Oliveira, Rodrigo Panno ^a,b   Pannain, Vera Lucia Nunes ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiogenesis; CD105; CD31; Gastrointestinal stromal tumors; Immunohistochemistry; Ki 67; Vascular endothelial growth factor

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; KI 67 ANTIGEN; PARAFFIN; VASCULOTROPIN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL STUDY; COLON TUMOR; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SMALL INTESTINE TUMOR; STOMACH TUMOR; TUMOR LOCALIZATION; TUMOR VOLUME; ANTIGEN DETECTION; ANTIGEN EXPRESSION; CAPILLARY DENSITY; CELL PROLIFERATION; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; ESOPHAGUS TUMOR; HISTOPATHOLOGY; HUMAN CELL; PROGNOSIS; PROTEIN DETERMINATION; REFERENCE VALUE; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR VASCULARIZATION; AREA UNDER THE CURVE; CHEMISTRY; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREDICTIVE VALUE; RISK FACTOR; SURVIVAL ANALYSIS; TIME FACTOR; VASCULARIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD31; AREA UNDER CURVE; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; ENDOGLIN; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84930850868     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6924     Document Type: Article

References (44)

1. Miettinen M, Lasota J. Histopathology of gastrointestinal stromal tumor. J Surg Oncol 2011; 104: 865-873 [PMID: 22069171 DOI: 10.1002/jso.21945]
2. Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology 2006; 48: 83-96 [PMID: 16359540]
3. Boichuk S, Parry JA, Makielski KR, Litovchick L, Baron JL, Zewe JP, Wozniak A, Mehalek KR, Korzeniewski N, Seneviratne DS, Schöffski P, Debiec-Rychter M, DeCaprio JA, Duensing A. The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis. Cancer Res 2013; 73: 5120-5129 [PMID: 23786773 DOI: 10.1158/0008-5472.CAN-13-0579]
4. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465 [PMID: 12094370]
5. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478 [PMID: 17090188]
6. Joensuu H. Predicting recurrence-free survival after surgery for GIST. Lancet Oncol 2009; 10: 1025 [PMID: 19793677 DOI: 10.1016/S1470-2045(09)70267-0].]
7. Huang H, Liu YX, Zhan ZL, Liang H, Wang P, Ren XB. Different sites and prognoses of gastrointestinal stromal tumors of the stomach: report of 187 cases. World J Surg 2010; 34: 1523-1533 [PMID: 20145924 DOI: 10.1007/s00268-010-0463-y]
8. Goh BK, Chow PK, Yap WM, Kesavan SM, Song IC, Paul PG, Ooi BS, Chung YF, Wong WK. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol 2008; 15: 2153-2163 [PMID: 18546045 DOI: 10.1245/s10434-008-9969-z]
9. Wong NA. Gastrointestinal stromal tumours-an update for histopathologists. Histopathology 2011; 59: 807-821 [PMID: 21668468 DOI: 10.1111/j.1365-2559.2011.03812.x]
10. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83 [PMID: 17193820]
11. Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 2012; 13: 265-274 [PMID: 22153892 DOI: 10.1016/ S1470-2045(11)70299-6]
12. Takahashi R, Tanaka S, Hiyama T, Ito M, Kitadai Y, Sumii M, Haruma K, Chayama K. Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 2003; 10: 797-802 [PMID: 12792726]
13. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006; 39: 469-478 [PMID: 17002866]
14. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-2049 [PMID: 18463380 DOI: 10.1056/NEJMra0706596]
15. Miao R, Liu N, Wang Y, Li L, Yu X, Jiang Y, Li J. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior. Hepatogastroenterology 2008; 55: 2012-2015 [PMID: 19260469]
16. Wang TB, Qiu WS, Wei B, Deng MH, Wei HB, Dong WG. Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. Ir J Med Sci 2009; 178: 315-320 [PMID: 19367428 DOI: 10.1007/ s11845-009-0315-7]
17. Imamura M, Yamamoto H, Nakamura N, Oda Y, Yao T, Kakeji Y, Baba H, Maehara Y, Tsuneyoshi M. Prognostic significance of angiogenesis in gastrointestinal stromal tumor. Mod Pathol 2007; 20: 529-537 [PMID: 17334345]
18. Takahashi R, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K, Chayama K. Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2003; 64: 266-274 [PMID: 12697968]
19. Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CP. Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors. J Biol Chem 2006; 281: 25110-25123 [PMID: 16785228]
20. Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ, Ellis LM. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008; 14: 1931-1937 [PMID: 18381930 DOI: 10.1158/1078-0432.CCR-07-4478]
21. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003; 116: 2677-2685 [PMID: 12746487]
22. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984-992 [PMID: 12773481]
23. Svatek RS, Karam JA, Roehrborn CG, Karakiewicz PI, Slawin KM, Shariat SF. Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy. Clin Cancer Res 2008; 14: 3362-3366 [PMID: 18519764 DOI: 10.1158/10780432. CCR-07-4707]
24. Bernabeu C, Lopez-Novoa JM, Quintanilla M. The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 2009; 1792: 954-973 [PMID: 19607914 DOI: 10.1016/ j.bbadis.2009.07.003]
25. Gromova P, Rubin BP, Thys A, Cullus P, Erneux C, Vanderwinden JM. ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours. J Cell Mol Med 2012; 16: 306-317 [PMID: 21435173 DOI: 10.1111/ j.1582-4934.2011.01315.x]
26. Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004; 64: 2941-2955 [PMID: 15126324]
27. Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, Tonini G. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IBIIA non-small cell lung cancer. J Clin Pathol 2004; 57: 591-597 [PMID: 15166262]
28. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005; 46: 481-489 [PMID: 15842629]
29. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8 [PMID: 1701519]
30. Weidner N. The importance of tumor angiogenesis: the evidence continues to grow. Am J Clin Pathol 2004; 122: 675-677 [PMID: 15491962]
31. Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, Riccobon A, Becciolini A, Bianchi S, Amadori D. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 2000; 89: 74-80 [PMID: 10719734]
32. Chen YY, Yeh CN, Cheng CT, Chen TW, Rau KM, Jan YY, Chen MF. Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World J Gastroenterol 2011; 17: 2113-2119 [PMID: 21547131 DOI: 10.3748/wjg.v17.i16.2113]
33. Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol 2005; 36: 828-837 [PMID: 16084954]
34. Hadlich MS, Oliveira GM, Feijóo RA, Azevedo CF, Tura BR, Ziemer PG, Blanco PJ, Pina G, Meira M, Souza e Silva NA. Free and open-source software application for the evaluation of coronary computed tomography angiography images. Arq Bras Cardiol 2012; 99: 944-951 [PMID: 23033110]
35. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a populationbased study in western Sweden. Cancer 2005; 103: 821-829 [PMID: 15648083]
36. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006; 30: 477-489 [PMID: 16625094]
37. Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 2011; 11: 865-878 [PMID: 22089421 DOI: 10.1038/nrc3143]
38. Ahmed I, Welch NT, Parsons SL. Gastrointestinal stromal tumours (GIST)-17 years experience from Mid Trent Region(United Kingdom). Eur J Surg Oncol 2008; 34: 445-449 [PMID: 17320340]
39. Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, Schleck CD, Hodge DO, Donohue JH. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008; 15: 52-59 [PMID: 18000711]
40. Oliveira RPB, Pannain VL, Portari Filho PE, Salomão AR, Iglesias AC, Oliveira CAB. Gastrointesinal stromal tumor: analysis of factors related to the prognostic. Rev Col Bras Cir 2007; 34: 374-380 [DOI: 10.1590/S0100-69912007000600004]
41. Zhao Y, Wang Q, Deng X, Zhao Y. Altered angiogenesis gene expression in gastrointestinal stromal tumors: potential use in diagnosis, outcome prediction, and treatment. Neoplasma 2012; 59: 384-392 [PMID: 22489693 DOI: 10.4149/neo-2012-050]
42. McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 2007; 13: 6727-6734 [PMID: 18006774]
43. Belev B, Brčić I, Prejac J, Golubić ZA, Vrbanec D, Božikov J, Alerić I, Boban M, Razumović JJ. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. World J Gastroenterol 2013; 19: 523-527 [PMID: 23382631 DOI: 10.3748/wjg.v19. i4.523]
44. Avanzolini G, Barbini P, Cappello A, Cevenini G. Real-time tracking of parameters of lung mechanics: emphasis on algorithm tuning. J Biomed Eng 1990; 12: 489-495 [PMID: 2266745]